Myofibroblast differentiation of normal human keratocytes and hTERT, extended-life human corneal fibroblasts

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 5, 2003, Pages 1850-1858

  Jester, James V ^a,b   Huang, Jiying ^a   Fisher, Stephen ^a   Spiekerman, Jennifer ^a   Chang, Jin Ho ^a   Wright, Woodring E ^b   Shay, Jerry W ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN; ARGINYLGLYCYLASPARTIC ACID; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; RETROVIRUS VECTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ADULT; AGE; ARTICLE; AUTOCRINE EFFECT; CELL CLONE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CHROMOSOME; CHROMOSOME ABERRATION; CONTROLLED STUDY; CORNEA CELL; FEEDBACK SYSTEM; FIBROBLAST CULTURE; FOCAL ADHESION; GENE; HUMAN; HUMAN CELL; HUMAN TELOMERASE REVERSE TRANSCRIPTASE GENE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MYOFIBROBLAST; NORMAL HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTINS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CHILD; CORNEAL STROMA; CULTURE MEDIA, SERUM-FREE; DNA-BINDING PROTEINS; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENETIC VECTORS; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TELOMERASE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037407652     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.02-0973     Document Type: Article

References (45)

1. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci USA. 1996;93:4219-4223.
2. Jester JV, Barry-Lane PA, Cavanagh HD, Petroll WM. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea. 1996;15:505-516.
3. Funderburgh JL, Funderburgh ML, Mann MM, Corpuz L, Roth MR. Proteoglycan expression during transforming growth factor beta-induced keratocyte-myofibroblast transdifferentiation. J Biol Chem. 2001;276:44173-44178.
4. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Temporal, 3-dimensional, cellular anatomy of corneal wound tissue. J Anat. 1995;186:301-311.
5. Petroll WM, Cavanagh HD, Barry P, Andrews P, Jester JV. Quantitative analysis of stress fiber orientation during corneal wound contraction. J Cell Sci. 1993;104:353-363.
6. Masur SK, Conors RJ, Cheung JK, Antohi S. Matrix adhesion characteristics of corneal myofibroblasts. Invest Ophthalmol Vis Sci. 1999;40:904-910.
7. Petridou S, Masur SK. Immunodetection of connexins and cadherins in corneal fibroblasts and myofibroblasts. Invest Ophthalmol Vis Sci. 1996;37:1740-1748.
8. Jester JV, Moller-Pedersen T, Huang J, et al. The cellular basis of corneal transparency: evidence for "corneal crystallins". J Cell Sci. 1999;112:613-622.
9. Jester JV, Barry-Lane PA, Petroll WM, Olsen DR, Cavanagh HD. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea. 1997;16:177-187.
10. Moller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res. 1998;17:736-747.
11. Wilson SE, He Y-G, Lloyd SA. EGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33:1756-1765.
12. Song QH, Singh RP, Richardson TP, Nugent MA, Trinkaus-Randall V. Transforming growth factor-beta1 expression in cultured corneal fibroblasts in response to injury. J Cell Biochem. 2000;77:186-199.
13. Massague J, Attisano L, Wrana L. The TGF-beta family and its composite receptors. Trends Cell Biol. 2997;4:172-178.
14. Massague J, Blain SW, Lo RS. TGF-beta signaling in growth control, cancer, and heritable disorders. Cell. 2000;103:295-309.
15. You L, Kruse FE. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway. Invest Ophthalmol Vis Sci. 2002;43:72-81.
16. Petridou S, Maltseva O, Spanakis S, Masur SK. TGF-beta receptor expression and Smad2 localization are cell density dependent in fibroblasts. Invest Ophthalmol Vis Sci. 2000;41:89-95.
17. Jester JV, Huang J, Petroll WM, Cavanagh HD. TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFb, PDGF and integrin signaling. Exp Eye Res. 2002;75:645-657.
18. Jester JV, Huang J, Barry-Lane PA, Kao WW, Petroll WM, Cavanagh HD. Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci. 1999;40:1959-1967.
19. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
20. Greider CW. Telomeres and senescence: the history, the experiment, the future. Curr Biol. 1998;8:R178-R181.
21. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
22. Steinert S, White DM, Zou Y, Shay JW, Wright WE. Telomere biology and cellular aging in nonhuman primate cells. Exp Cell Res. 2002;272:146-152.
23. Egan CA, Savre-Train I, Shay JW, Wilson SE, Bourne WM. Analysis of telomere lengths in human corneal endothelial cells from donors of different ages. Invest Ophthalmol Vis Sci. 1998;39:648-653.
24. Beales MP, Funderburgh JL, Jester JV, Hassell JR. Proteoglycan synthesis by bovine keratocytes and corneal fibroblasts: maintenance of the keratocyte phenotype in culture. Invest Ophthalmol Vis Sci. 1999;40:1658-1663.
25. Kirschner SE, Ciaccia A, Ubels JL. The effect of retinoic acid on thymidine incorporation and morphology of corneal stromal fibroblasts. Curr Eye Res. 1990;9:1121-1125.
26. Pattenati MJ, Sweatt AJ, Lantz P, et al. The human cornea has a high incidence of acquired chromosome abnormalities. Hum Genet. 1997;101:26-29.
27. Funderburgh JL, Funderburgh ML, Mann MM, Roth MM. Extracellular matrix expression and cytoskeletal changes during corneal fibrosis: are fibroblasts an obligatory precursor to myofibroblasts? (Abstract). Exp Eye Res. 2000;71:S153.
28. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. Ah SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
29. Griffith M, Osborne R, Munger R, et al. Functional human corneal equivalents constructed from cell lines. Science. 1999;286:2169-2172.
30. He Y-G, Weng J, Li Q, Knauf HP, Wilson SE. Fuch's corneal endothelial cells transduced with the human papilloma virus E6/E7 oncogenes. Exp Eye Res. 1997;65:135-142.
31. Kahn CR, Young E, Lee IH, Rhim JS. Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies. Invest Ophthalmol Vis Sci. 1993;34:3429-3441.
32. Offord EA, Sharif NA, Mace K, et al. Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci. 1999;40:1091-1101.
33. Wilson SE, Mohan RR, Possin DE, Mohan RR. Extended life of human corneal endothelial cells transfected with the SV40 large T antigen. Invest Ophthalmol Vis Sci. 1993;34:2112-2123.
34. Wilson WE, Weng J, Blair S, He Y-G, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36:32-40.
35. Barry-Lane PA, Wilson SE, Cavanagh HD, Petroll WM, Jester JV. Characterization of SV40-transfected cell strains from rabbit keratocytes. Cornea. 1997;16:72-78.
36. Hoffschir F, Ricoul M, Lemieux N, Estrade S, Cassingena R, Dutrillaux B. Jumping translocations originate clonal rearrangements in SV40-transformed human fibroblasts. Int J Cancer. 1992;52:130-136.
37. Gu W, Schneider JW, Condorelli G, et al. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 1993;72:309-324.
38. Hamel PA, Phillips RA, Muncaster M, Gallie BL. Speculations on the role of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 1993;7:846-854.
39. Forsyth NR, Wright WE, Shay JW. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation. 2002;29:188-197.
40. Jester JV, Barry PA, Lind GJ, Petroll WM, Garana R, Cavanagh HD. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins. Invest Ophthalmol Vis Sci. 1994;35:730-743.
41. Jester JV, Villasenor RA, Schanzlin DJ, Cavanagh HD. Variations in corneal wound healing after radial keratotomy: possible insights into mechanisms of clinical complications and refractive effects. Cornea. 1992;11:191-199.
42. Lynn MJ, Waring GO, Kutner MH. Predictability of refractive keratotomy. In: Kist K, ed. Refractive Keratotomy for Myopia and Astigmatism. St. Louis: Mosby Year Book; 1992:374-376.
43. Rao NA, Thaete LG, Delmage JM, Sevanian A. Superoxide dismutase in ocular structures. Invest Ophthalmol Vis Sci. 1985;26:1778-1781.
44. Cai CX, Linsenmayer TF. Nuclear translocation of ferritin in corneal epithelial cells. J Cell Sci. 2001;114:2327-2334.
45. Maurer JK, Molai A, Parker RD, et al. Pathology of ocular irritation with bleaching agents in the rabbit low-volume eye test. Toxicol Pathol. 2001;29:308-319.